<DOC>
	<DOCNO>NCT02134340</DOCNO>
	<brief_summary>The purpose study evaluate safety biodistribution [ I-124 ] -CPD-1028 Injection cancer patient solid tumour .</brief_summary>
	<brief_title>A Safety Biodistribution Study I-124-CPD-1028 Injection Solid Tumours</brief_title>
	<detailed_description>Up 18 adult participant enrol Phase 1a study evaluate safety biodistribution [ I-124 ] -CPD-1028 Injection patient Insulin-like Growth Factor-1R ( IGF-1R ) upregulated solid tumour . All eligible subject give write informed consent qualify base study 's inclusion/exclusion criterion enrol study . Each enrol subject take part six visit consist screen visit , Investigational Product administration visit , 3 assessment visit involve 2-3 Positron Emission Tomography/Computed Tomography ( PET/CT ) scan , follow-up safety telephone call . At Visit 2 , subject start course treatment protect thyroid radioactivity may receive pre-targeting dose additional investigational agent , CPD-1061 .</detailed_description>
	<criteria>1 . Age â‰¥18 year old life expectancy &gt; 12 week confirm metastatic unresectable malignancy 2 . Patients must progress least firstline chemotherapy Eastern Cooperative Oncology Group ( ECOG ) status 0 , 1 2 . 3 . All patient must archival tumour sample available must verification IGF1R expression . 4 . Patients must adequate organ marrow function , vital sign ECG . 5 . Females childbearing potential must pregnant male female must use adequate form contraception . 6 . Signed informed consent form 7 . Subject must compliant high probability complete study . 1 . Patients chemotherapy radiotherapy within 2 week prior enter study recover previous treatment . 2 . Patients receive therapeutic radiopharmaceutical past year currently receive investigational agent . 3 . Previous treatment IGF1R inhibitor . 4 . Patients currently take antithyroid medication lithium potassium spar diuretic . 5 . Subjects know suspected allergy contraindication investigational agent iodine 6 . Subjects uncontrolled intercurrent illness 7 . Female subject pregnant , plan become pregnant lactate and/or breastfeeding . 8 . Patients diabetes require therapy unless control diet metformin . 9 . Subjects undergo monitor occupational ionising radiation exposure . 10 . Subjects hypothyroidism require thyroid supplementation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>IGF1R</keyword>
</DOC>